J
Jiangang Liu
Researcher at Eli Lilly and Company
Publications - 7
Citations - 1880
Jiangang Liu is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Medicine & CD90. The author has an hindex of 3, co-authored 3 publications receiving 1431 citations.
Papers
More filters
Journal ArticleDOI
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu,Jeeyun Lee,Michael Nebozhyn,Kyoung-Mee Kim,Jason C. Ting,Swee Seong Wong,Jiangang Liu,Yong Gang Yue,Jian Wang,Kun Yu,Xiang S. Ye,In-Gu Do,Shawn Liu,Lara Gong,Jake Fu,Jason Gang Jin,Min Gew Choi,Tae Sung Sohn,Joon-Ho Lee,Jae Moon Bae,Seung Tae Kim,Se Hoon Park,Insuk Sohn,Sin-Ho Jung,Patrick Tan,Ronghua Chen,James S. Hardwick,Won Ki Kang,Mark Ayers,Dai Hongyue,Christoph Reinhard,Andrey Loboda,Sung Kim,Amit Aggarwal +33 more
TL;DR: This work uses gene expression data to describe four molecular subtypes linked to distinct patterns of molecular alterations, disease progression and prognosis in gastric cancer, and describes key molecular alterations in each of the four subtypes using targeted sequencing and genome-wide copy number microarrays.
Journal ArticleDOI
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan,Hancheng Zheng,Xiao Liu,Shuyu Li,Thomas D. Barber,Zhuolin Gong,Huan Gao,Ke Hao,Melinda D. Willard,Jiangchun Xu,Robert Hauptschein,Paul A. Rejto,Julio Fernandez,Guan Wang,Qinghui Zhang,Bo Wang,Ronghua Chen,Jian Wang,Nikki P. Lee,Wei Zhou,Zhao Lin,Zhiyu Peng,Kang Yi,Shengpei Chen,Lin Li,Xiaomei Fan,Jie Yang,Rui Ye,Jia Ju,Kai Wang,Heather Estrella,Shibing Deng,Ping Wei,Ming Qiu,Isabella H. Wulur,Jiangang Liu,Mariam Ehsani,Chunsheng Zhang,Andrey Loboda,Wing-Kin Sung,Wing-Kin Sung,Amit Aggarwal,Ronnie T.P. Poon,Sheung Tat Fan,Jun Wang,James S. Hardwick,James S. Hardwick,Christoph Reinhard,Hongyue Dai,Yingrui Li,John M. Luk,John M. Luk,John M. Luk,Mao Mao,Mao Mao +54 more
TL;DR: Findings from a whole-genome sequencing study of 88 matched HCC tumor/normal pairs, 81 of which are Hepatitis B virus (HBV) positive, find beta-catenin to be the mostrequently mutated oncogene and TP53 the most frequently mutated tumor suppressor.
Journal ArticleDOI
Stromal-Based Signatures for the Classification of Gastric Cancer
Mark T. Uhlik,Jiangang Liu,Beverly L. Falcon,Seema Iyer,Julie Stewart,Hilal Celikkaya,Marguerita O’Mahony,Christopher J. Sevinsky,Christina Lowes,Larry E. Douglass,Cynthia Jeffries,Diane M. Bodenmiller,Sudhakar Chintharlapalli,Anthony S. Fischl,Damien Gerald,Qi Xue,Jeeyun Lee,Alberto Santamaria-Pang,Yousef Al-Kofahi,Yunxia Sui,Keyur Desai,Thompson N. Doman,Amit Aggarwal,Julia H. Carter,Bronislaw Pytowski,Shou-Ching S. Jaminet,Fiona Ginty,Aejaz Nasir,Janice A. Nagy,Harold F. Dvorak,Laura E. Benjamin +30 more
TL;DR: It is suggested that a genomics-based systems approach focused on the tumor stroma can be used to discover putative predictive biomarkers of treatment response, especially to antiangiogenesis agents and immunotherapy, thus offering an opportunity to improve patient stratification.
Journal ArticleDOI
USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion.
Yuanshuai Zhou,Xingjun Meng,W. He,Xin Li,Rongchuan Zhao,Caihua Dong,Detian Yuan,Jiao Yang,Ruobing Zhang,Guohua Shi,Yulun Huang,Jiangang Liu,Jian-ping Liu,Songbai Liu,Peng Fu,Minxuan Sun +15 more
TL;DR: Mechanistic studies reveal that USF1 promotes GSC's stemness by directly regulating CD90 expression, and the overexpression of CD90 restores the stemness property in USf1 knockdown GSCs and its immunosuppressive microenvironment.
Journal ArticleDOI
Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
TL;DR: Plasma Gal-3 might be employed as an additional predictor for new-onset HFpEF, the adverse prognosis inHFpEF patients (all-cause death, the composite endpoints of all- cause death and HF hospitalization or CV death andHF hospitalization), and the severity of LVDD in HFp EF populations.